Tianjin Chase Sun Pharmaceutical Co Ltd
SZSE:300026
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SZSE:300026
|
CN |
|
Mansi Finance (Chennai) Ltd
BSE:511758
|
IN |
|
T
|
Tibet Development Co Ltd
SZSE:000752
|
CN |
|
KRM22 PLC
LSE:KRM
|
UK |
|
S
|
Snowline Gold Corp
CNSX:SGD
|
CA |
|
R
|
Renhe Pharmacy Co Ltd
SZSE:000650
|
CN |
|
S
|
Shandong Molong Petroleum Machinery Co Ltd
OTC:SHANF
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Tianjin Chase Sun Pharmaceutical Co Ltd's stock price target?
Not Available
Tianjin Chase Sun Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Tianjin Chase Sun Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
109%
For the last 13 years the
compound annual growth rate for
Tianjin Chase Sun Pharmaceutical Co Ltd's revenue is
20%.
The projected
CAGR
for the next 1 year is
109%.
What is Tianjin Chase Sun Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
34%
For the last 13 years the
compound annual growth rate for
Tianjin Chase Sun Pharmaceutical Co Ltd's operating income is
-5%.
The projected
CAGR
for the next 7 years is
34%.
What is Tianjin Chase Sun Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
6 967%
For the last 13 years the
compound annual growth rate for
Tianjin Chase Sun Pharmaceutical Co Ltd's net income is
-13%.
The projected
CAGR
for the next 1 year is
6 967%.
